CNTA
Centessa Pharmaceuticals PLC ADR
NASDAQ: CNTA · HEALTHCARE · BIOTECHNOLOGY
$39.45
-0.03% today
Updated 2026-04-29
Market cap
$6.10B
P/E ratio
—
P/S ratio
406.76x
EPS (TTM)
$-1.46
Dividend yield
—
52W range
$11 – $40
Volume
3.0M
WallStSmart proprietary scores
24
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C7.3
Quality
B+2.5
Profitability
F5.0
Valuation
C+5/9
Piotroski F-Score
Moderate
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
$44.57
+12.98%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
1 Strong Buy8 Buy4 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ Debt/equity 0.39x — low leverage
Risks
- Thin margins at 0.00%
- Negative free cash flow $-55.82M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $6.85M | $0.00 | $15.00M | $15.00M |
| Net income | $-216.21M | $-151.09M | $-235.76M | $-197.53M | $-66.16M |
| EPS | — | — | — | — | $-1.46 |
| Free cash flow | $-201.68M | $-160.51M | $-142.09M | $-194.19M | $-55.82M |
| Profit margin | — | -2,204.65% | — | -1,316.88% | — |
Peer comparison
Smart narrative
Centessa Pharmaceuticals PLC ADR trades at $39.45. Our Smart Value Score of 24/100 indicates the stock is weak. The company scores 5/9 on the Piotroski F-Score. TTM revenue stands at $15.00M.
Frequently asked questions
What is Centessa Pharmaceuticals PLC ADR's stock price?
Centessa Pharmaceuticals PLC ADR (CNTA) trades at $39.45.
Is Centessa Pharmaceuticals PLC ADR overvalued?
Smart Value Score 24/100 (Grade F, Strong Sell).
What is the price target of Centessa Pharmaceuticals PLC ADR (CNTA)?
The analyst target price is $44.57, representing +13.0% upside from the current price of $39.45.
What is Centessa Pharmaceuticals PLC ADR's revenue?
TTM revenue is $15.00M.
Piotroski F-Score?
5/9 — moderate financial health.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio406.76x
ROE-42.50%
Beta1.26
50D MA$32.29
200D MA$24.92
Shares out0.15B
Float0.10B
Short ratio—
Avg volume3.0M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—